Expression of cell cycle regulators during smooth muscle cell proliferation after balloon catheter injury of rat artery

Journal of Korean Medical Science

Volumn 19, Issue 3, 2004, Pages 327-332

  Chung, Jung Kee ^b   Lee, Taeseung ^c   Jung, In Mok ^b   Kim, Young Kyun ^e   Min, Seung Kee ^d   Suh, Jeong Wook ^a   Kim, Sang Joon ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Boramae Hospital   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Gachon University College of Medicine   (South Korea)

^e NONE

Author keywords

Cell Cycle Proteins; Endothelium; Myocytes; Rat; Smooth Muscle; Tunica Intima; Vascular

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN E; CYCLINE; PROTEIN P21; PROTEIN P27;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; BALLOON CATHETER; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ILIAC ARTERY; KINETICS; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER;

EID: 3042799969     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2004.19.3.327     Document Type: Article

References (25)

1. Herman JP, Herman WR, Vos J, Serruys PW. Pharmacological approaches to the prevention of restenosis following angioplasty: the search for the Holy Grail? Drugs 1993; 46: 18-52.
2. Ross R. Cell biology of atherosclerosis. Ann Rev Physiol 1995; 57: 791-804.
3. Walker LN, Bowne-Pope DF, Ross R, Reidy MA. Production of platelet derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferating after arterial injury. Proc Natl Acad Sci USA 1986; 83: 7311-5.
4. Warner SJ, Libby P. Human vascular smooth muscle cells: target for and source of tumor necrosis factor. J Immunol 1989; 142: 100-9.
5. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs. hyperplasia: autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest 1992; 90: 456-61.
6. Gospodarowicz D, Ferrara N, Haaparanta T, Neufeld G. Basic fibroblast growth factor: expression in cultured bovine vascular smooth muscle cells. Eur J Cell Biol 1988; 46: 144-51.
7. Owens GK. Regualtion of differentiation of vascular smooth muscle cells. Physiol Rev 1995; 75: 487-517.
8. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242-50.
9. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9.
10. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury: Smooth muscle growth in the absence of endothelium. Lab Invest 1983; 49: 327-33.
11. Geary RL, Williams JK, Golden D, Brown DG, Benjamin ME, Adams MR. Time course of cellular proliferation, intimal hyperplasia, and remodeling following angioplasty in monkeys with established atherosclerosis. Arterioscler Thromb Vasc Biol 1996; 16: 34-43.
12. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 1991; 88: 3739-43.
13. Benett MR, Anglin S, McEwan JR, Jagoe R, newby AC, Evan GI. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. J Clin Invest 1994; 93: 820-8.
14. Nabel EG, Yang Z, Liptay S, San H, Gordon D, Haundenschild CC, Nabel GJ. Recombinant platelet-derived growth factor-B gene expression in porcine arteries induce intimal hyperplasia in vivo. J Clin Invest 1993; 91: 1822-9.
15. King RW, Jackson PK, Kirschner MW. Mitosis in transition. Cell 1994; 79: 563-71.
16. Nurse P. Ordering S phase and M phase in the cell cycle. Cell 1994; 79: 547-50.
17. Su TT, Stumpff J. Promiscuity rules? The dispensability of cyclin E and Cdk2. Sci STKE 2004; 2004: 11.
18. Morgan DO. Principles of CDK regulation. Nature 1995; 374: 131-4.
19. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin dependent kinases. Genes Dev 1995; 9: 1149-63.
20. Pagano M, Pepperkok R, Lukas J, Baldin V, Ansorge W, Bartek J, Draetta G. Regulation of the cell cycle the cdk2 protein kinase in cultured human fibroblasts. J Cell Biol 1993; 121: 101-11.
21. Tsai L, Lees E, Faha B, harlow E, Riabowol K. The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene 1993; 8: 1593-602.
22. Wengrovitz M, Selassie LG, Gifford RR, Thiele BL. Cyclosporine inhibits the development of medial thickening after experimental arterial injury. J Vasc Surg 1990; 12: 1-7.
23. Gabeler EE, van Hillegersberg R, Statius van Eps RG, Sluiter W, Mulder P, van Urk H. A comparison of balloon injury models of endovascular lesions in rat arteries. BMC Cardiovasc Disord 2002; 2: 16.
24. Sherr CJ. Mammalian G1 cyclins. Cell 1993; 73: 1059-65.
25. Belknap JK, Grieshaber NA, Schwartz PE, Orton EC, Reidy MA, Majack RA. Tropoelastin gene expression in individual vascular smooth muscle cells: relationship to DNA synthesis during vascular development and after arterial injury. Circ Res 1996; 78: 388-94.